Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson’s Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson’s Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation
Authors
Keywords
-
Journal
ACS Pharmacology & Translational Science
Volume 6, Issue 1, Pages 40-51
Publisher
American Chemical Society (ACS)
Online
2022-12-15
DOI
10.1021/acsptsci.2c00120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correction to: Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson’s Like Symptoms Without Loss of Dopaminergic Neurons
- (2022) Monika Sharma et al. NEUROTOXICITY RESEARCH
- Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway
- (2021) Taruna Pandey et al. BIOORGANIC CHEMISTRY
- Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin – A Promising Natural Lead for New Drug Discovery and Development
- (2021) Nur Sakinah Muhamad Fadzil et al. Drug Design Development and Therapy
- Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
- (2020) Mónica Gómez-Benito et al. Frontiers in Pharmacology
- Glial cells in Parkinson´s disease: protective or deleterious?
- (2020) Ana V. Domingues et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson’s disease
- (2020) Ariana Q. Farrand et al. Brain Stimulation
- Neuroprotective Effect of Swertiamain on Cerebral Ischemia/Reperfusion Injury by Inducing the Nrf2 Protective Pathway
- (2019) Hui Wang et al. ACS Chemical Neuroscience
- A natural AKT inhibitor swertiamarin targets AKT‐PH domain, inhibits downstream signaling, and alleviates inflammation
- (2019) Man Zhang et al. FEBS Journal
- Effects of Exercise on Non-motor Symptoms in Parkinson’s Disease
- (2018) Amy W. Amara et al. CLINICAL THERAPEUTICS
- Effect of moxibustion on mTOR-mediated autophagy in rotenone-induced Parkinson's disease model rats
- (2018) Jun Ma et al. Neural Regeneration Research
- Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson’s Disease
- (2017) Dmitri Leonoudakis et al. MEDIATORS OF INFLAMMATION
- Anti-inflammatory activity of compounds isolated from Swertia mussotii
- (2017) Yuan Xiang et al. NATURAL PRODUCT RESEARCH
- Anticonvulsant Effect of Swertiamarin Against Pilocarpine-Induced Seizures in Adult Male Mice
- (2017) Xian-Hua Deng et al. NEUROCHEMICAL RESEARCH
- Motor and Non-Motor Symptoms in Parkinson’s Disease: Effects on Quality of Life
- (2017) Elif GOKCAL et al. Noropsikiyatri Arsivi-Archives of Neuropsychiatry
- Gut–brain and brain–gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet
- (2017) Paula Perez-Pardo et al. NUTRITIONAL NEUROSCIENCE
- An update on the diagnosis and treatment of Parkinson disease
- (2016) Philippe Rizek et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease
- (2016) Kyung Moon Lee et al. JOURNAL OF NEUROSCIENCE RESEARCH
- A quantitative 1H nuclear magnetic resonance (qHNMR) method for assessing the purity of iridoids and secoiridoids
- (2015) Zeyun Li et al. FITOTERAPIA
- Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritis
- (2014) S. Saravanan et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson’s disease
- (2014) C.H. Carriere et al. NEUROSCIENCE
- Environmental Toxins and Parkinson's Disease
- (2013) Samuel M. Goldman Annual Review of Pharmacology and Toxicology
- Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models
- (2013) Wenjiao Tai et al. NEUROPHARMACOLOGY
- Rotenone Upregulates Alpha-Synuclein and Myocyte Enhancer Factor 2D Independently from Lysosomal Degradation Inhibition
- (2013) Gessica Sala et al. Biomed Research International
- Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat
- (2012) Deirdre B. Hoban et al. BRAIN BEHAVIOR AND IMMUNITY
- Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease
- (2012) Anamitra Ghosh et al. Journal of Neuroinflammation
- Anti-diabetic Activity of Swertiamarin is due to an Active Metabolite, Gentianine, that Upregulates PPAR-γ Gene Expression in 3T3-L1 cells
- (2012) Hitesh Vaidya et al. PHYTOTHERAPY RESEARCH
- Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone
- (2011) P. Mulcahy et al. NEUROSCIENCE
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson’s disease
- (2010) Shane Grealish et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- A rotarod test for evaluation of motor skill learning
- (2010) Hiromi Shiotsuki et al. JOURNAL OF NEUROSCIENCE METHODS
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- PPAR: a therapeutic target in Parkinsons disease
- (2008) Rajnish K. Chaturvedi et al. JOURNAL OF NEUROCHEMISTRY
- Antinociceptive activity of swertiamarin isolated from Enicostemma axillare
- (2008) V. Jaishree et al. PHYTOMEDICINE
- Antiedematogenic and Free Radical Scavenging Activity of Swertiamarin Isolated fromEnicostemma axillare
- (2008) Jaishree Vaijanathappa et al. PLANTA MEDICA
- Glial reactions in Parkinson's disease
- (2007) Patrick L. McGeer et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started